Nirogy Therapeutics

Nirogy Therapeutics

Biotechnology, 175 Crossing BLVD, Framingham, , 1702, Massachusetts, United States, 1-10 Employees

nirogytx.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 50********

Who is NIROGY THERAPEUTICS

Nirogy Therapeutics is a biotechnology company based in Boston, MA developing novel small molecules to target cellular transporters. The company is currently advancing a class of small mo...

Read More

map
  • 175 Crossing BLVD, Framingham, Massachusetts, 1702, United States Headquarters: 175 Crossing BLVD, Framingham, Massachusetts, 1702, United States
  • 2014 Date Founded: 2014
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from NIROGY THERAPEUTICS

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Nirogy Therapeutics

Answer: Nirogy Therapeutics's headquarters are located at 175 Crossing BLVD, Framingham, , 1702, Massachusetts, United States

Answer: Nirogy Therapeutics's phone number is 50********

Answer: Nirogy Therapeutics's official website is https://nirogytx.com

Answer: Nirogy Therapeutics's revenue is Under $1 Million

Answer: Nirogy Therapeutics's SIC: 2836

Answer: Nirogy Therapeutics's NAICS: 541714

Answer: Nirogy Therapeutics has 1-10 employees

Answer: Nirogy Therapeutics is in Biotechnology

Answer: Nirogy Therapeutics contact info: Phone number: 50******** Website: https://nirogytx.com

Answer: Nirogy Therapeutics is a biotechnology company based in Boston, MA developing novel small molecules to target cellular transporters. The company is currently advancing a class of small molecules intended to disrupt metabolic and immune mechanisms operative in the tumor microenvironment. Follow-on platform programs are targeting additional disease pathways in oncology as well as autoimmune diseases.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access